Carlsmed, Inc. (CARL) — Financial statements
Income statement, balance sheet, and cash flow for Carlsmed, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | |
|---|---|---|
| Revenue & Gross Profit | ||
| Revenue | 51 | |
| Cost of Revenue | 12 | |
| Gross Profit | 38 | |
| Operating Expenses | ||
| R&D Expenses | 17 | |
| General & Administrative Expenses | 17 | |
| Selling & Marketing Expenses | 35 | |
| SG&A Expenses | 52 | |
| Other Expenses | 0.00 | |
| Operating Expenses | 69 | |
| Total Costs & Expenses | 81 | |
| Operating Results | ||
| Operating Income | -31 | |
| Depreciation & Amortization | 0.28 | |
| EBITDA | -29 | |
| EBIT | -29 | |
| Interest & Other Income | ||
| Net Interest Income | 1 | |
| Interest Income | 3 | |
| Interest Expense | 1 | |
| Non-Operating Income | -2 | |
| Other Income / Expenses | 0.36 | |
| Income Before Tax | -30 | |
| Income Tax Expense | 0.00 | |
| Net Income & EPS | ||
| Net Income from Continuing Operations | -30 | |
| Net Income from Discontinued Operations | 0.00 | |
| Net Income | -30 | |
| Bottom-Line Net Income | -30 | |
| EPS (Basic) | -2.12 | |
| EPS (Diluted) | -2.12 | |
| Weighted Average Shares | 14 | |
| Weighted Average Diluted Shares | 14 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.